INTERNATIONAL PATENT: KYRON.BIO SAS FILES APPLICATION FOR "THERAPEUTIC MOLECULES THAT BIND TNF ALPHA"

GENEVA, May 4 -- KYRON.BIO SAS (10 rue de Penthièvre75008 Paris) filed a patent application (PCT/EP2025/080856) for "THERAPEUTIC MOLECULES THAT BIND TNF ALPHA" on Oct 24, 2025. With publication no. WO/2026/087776, the details related to the patent application was published on Apr 30, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MCLAUGHLIN, Emilia Jane (10 rue de Penthièvre75008 Paris), LOCHHEAD, Marina Rose (10 rue de Penthièvre75008 Paris)

Abstract: The present invention relates to methods for engineering the variable region of antibodies or antigen binding fragments t...